An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.
Kaminsky, Erin B. PhD 1; Kaul, Vineith MS 1; Paschall, Justin PhD 2; Church, Deanna M. PhD 2; Bunke, Brian BS 1; Kunig, Dawn BS 1; Moreno-De-Luca, Daniel MD, MSc 1; Moreno-De-Luca, Andres MD 1; Mulle, Jennifer G. MHS, PhD 1; Warren, Stephen T. PhD 1,3; Richard, Gabriele MD 4; Compton, John G. PhD 4; Fuller, Amy E. MS 4; Gliem, Troy J. BS 5; Huang, Shuwen PhD 6,7; Collinson, Morag N. BS 6; Beal, Sarah J. BS 6; Ackley, Todd BS 8; Pickering, Diane L. MS 9; Golden, Denae M. BS 9; Aston, Emily BS 10; Whitby, Heidi BS 10; Shetty, Shashirekha PhD 10; Rossi, Michael R. PhD 1; Rudd, M. Katharine PhD 1; South, Sarah T. PhD 10; Brothman, Arthur R. PhD 10; Sanger, Warren G. PhD 9; Iyer, Ramaswamy K. PhD 8; Crolla, John A. PhD 6,7; Thorland, Erik C. PhD 5; Aradhya, Swaroop PhD 4; Ledbetter, David H. PhD 1; Martin, Christa L. PhD 1
Genetics in Medicine.
13(9):777-784, September 2011.
(Format: HTML, PDF)
Purpose: Copy number variants have emerged as a major cause of human disease such as autism and intellectual disabilities. Because copy number variants are common in normal individuals, determining the functional and clinical significance of rare copy number variants in patients remains challenging. The adoption of whole-genome chromosomal microarray analysis as a first-tier diagnostic test for individuals with unexplained developmental disabilities provides a unique opportunity to obtain large copy number variant datasets generated through routine patient care.
Methods: A consortium of diagnostic laboratories was established (the International Standards for Cytogenomic Arrays consortium) to share copy number variant and phenotypic data in a central, public database. We present the largest copy number variant case-control study to date comprising 15,749 International Standards for Cytogenomic Arrays cases and 10,118 published controls, focusing our initial analysis on recurrent deletions and duplications involving 14 copy number variant regions.
Results: Compared with controls, 14 deletions and seven duplications were significantly overrepresented in cases, providing a clinical diagnosis as pathogenic.
Conclusion: Given the rapid expansion of clinical chromosomal microarray analysis testing, very large datasets will be available to determine the functional significance of increasingly rare copy number variants. This data will provide an evidence-based guide to clinicians across many disciplines involved in the diagnosis, management, and care of these patients and their families.
(C)2011The American College of Medical Genetics